Metropolitan Life Insurance Company (MetLife)’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-847
| Closed | -$58.6K | – | 143 |
|
|
2024
Q1 | $58.6K | Hold |
847
| – | – | ﹤0.01% | 1326 |
|
|
2023
Q4 | $46.7K | Hold |
847
| – | – | ﹤0.01% | 1486 |
|
|
2023
Q3 | $49.2K | Buy |
847
+74
| +10% | +$4.27K | ﹤0.01% | 1417 |
|
|
2023
Q2 | $41.6K | Hold |
773
| – | – | ﹤0.01% | 1529 |
|
|
2023
Q1 | $30.7K | Hold |
773
| – | – | ﹤0.01% | 1671 |
|
|
2022
Q4 | $31.1K | Hold |
773
| – | – | ﹤0.01% | 1768 |
|
|
2022
Q3 | $24.8K | Hold |
773
| – | – | ﹤0.01% | 1909 |
|
|
2022
Q2 | $22.9K | Hold |
773
| – | – | ﹤0.01% | 1984 |
|
|
2022
Q1 | $21.7K | Sell |
773
-2,127
| -73% | -$79.3K | ﹤0.01% | 2051 |
|
|
2021
Q4 | $134K | Hold |
2,900
| – | – | ﹤0.01% | 2295 |
|
|
2021
Q3 | $95.2K | Buy |
+2,900
| New | +$90.2K | ﹤0.01% | 2551 |
|
|
2021
Q1 | – | Sell |
-2,743
| Closed | -$79.7K | – | 2588 |
|
|
2020
Q4 | $79.7K | Hold |
2,743
| – | – | ﹤0.01% | 2430 |
|
|
2020
Q3 | $77.4K | Hold |
2,743
| – | – | ﹤0.01% | 2361 |
|
|
2020
Q2 | $88.7K | Hold |
2,743
| – | – | ﹤0.01% | 2328 |
|
|
2020
Q1 | $112K | Sell |
2,743
-810
| -23% | -$43.1K | ﹤0.01% | 1966 |
|
|
2019
Q4 | $219K | Hold |
3,553
| – | – | ﹤0.01% | 1857 |
|
|
2019
Q3 | $259K | Buy |
3,553
+681
| +24% | +$51K | ﹤0.01% | 1699 |
|
|
2019
Q2 | $236K | Hold |
2,872
| – | – | ﹤0.01% | 1787 |
|
|
2019
Q1 | $203K | Hold |
2,872
| – | – | ﹤0.01% | 1893 |
|
|
2018
Q4 | $129K | Hold |
2,872
| – | – | ﹤0.01% | 2108 |
|
|
2018
Q3 | $162K | Hold |
2,872
| – | – | ﹤0.01% | 2152 |
|
|
2018
Q2 | $192K | Hold |
2,872
| – | – | ﹤0.01% | 1969 |
|
|
2018
Q1 | $167K | Hold |
2,872
| – | – | ﹤0.01% | 2001 |
|
|
2017
Q4 | $185K | Sell |
2,872
-2,912
| -50% | -$181K | ﹤0.01% | 1957 |
|
|
2017
Q3 | $304K | Hold |
5,784
| – | – | ﹤0.01% | 2021 |
|
|
2017
Q2 | $271K | Hold |
5,784
| – | – | ﹤0.01% | 2147 |
|
|
2017
Q1 | $286K | Hold |
5,784
| – | – | ﹤0.01% | 2037 |
|
|
2016
Q4 | $351K | Hold |
5,784
| – | – | ﹤0.01% | 1975 |
|
|
2016
Q3 | $384K | Sell |
5,784
-490
| -8% | -$30.6K | ﹤0.01% | 1871 |
|
|
2016
Q2 | $350K | Sell |
6,274
-1,305
| -17% | -$63.4K | ﹤0.01% | 1914 |
|
|
2016
Q1 | $255K | Buy |
7,579
+2,410
| +47% | +$81.7K | ﹤0.01% | 2026 |
|
|
2015
Q4 | $233K | Hold |
5,169
| – | – | ﹤0.01% | 2147 |
|
|
2015
Q3 | $204K | Sell |
5,169
-459
| -8% | -$26.1K | ﹤0.01% | 2263 |
|
|
2015
Q2 | $349K | Buy |
5,628
+319
| +6% | +$19K | ﹤0.01% | 2009 |
|
|
2015
Q1 | $332K | Hold |
5,309
| – | – | ﹤0.01% | 1781 |
|
|
2014
Q4 | $299K | Sell |
5,309
-2,599
| -33% | -$115K | ﹤0.01% | 2124 |
|
|
2014
Q3 | $224K | Hold |
7,908
| – | – | ﹤0.01% | 2291 |
|
|
2014
Q2 | $272K | Buy |
+7,908
| New | +$248K | ﹤0.01% | 2285 |
|
Other funds holding ANIP
RCMNY
GACM
DTC
TCM
Metropolitan Life Insurance Company (MetLife)'s ANIP Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of ANI Pharmaceuticals (ANIP) in Q2 2024, closing a stake of 847 shares — an estimated $58.6K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ANIP in Q2 2014 and held it in 38 quarters. The position peaked at $384K in Q3 2016. 201 funds tracked by Wall St. Rank hold ANIP as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining ANI Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 847 ANI Pharmaceuticals shares in Q2 2024, an estimated $58.6K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in ANI Pharmaceuticals in Q2 2014 and held it in 38 quarters.
- Metropolitan Life Insurance Company (MetLife)'s ANI Pharmaceuticals position peaked at $384K in Q3 2016.
- 201 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.